Sign in
4

Changes in Ownership

ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001209191-19-060507

Chief Executive Officer sold 183,333 shares at an average $67.15 ($12,310,119)

From the SEC's structured data for this filing

Trades in this filing

Anzalone Christopher Richard · Chief Executive Officer

Table I: Non-derivative

8 lines
Date Transaction Shares Price Value Owned after D/I
2019-12-12 Sale : show line 1 in the form −23,219 $66.82 $1,551,494 2,048,684 D
2019-12-12 Sale : show line 2 in the form −58,059 $67.31 $3,907,951 1,990,625 D
2019-12-12 Sale : show line 3 in the form −10,343 $68.51 $708,599 1,980,282 D
2019-12-12 Sale : show line 4 in the form −8,379 $69.41 $581,586 1,971,903 D
2019-12-13 Sale : show line 5 in the form −8,951 $65.85 $589,423 1,962,952 D
2019-12-13 Sale : show line 6 in the form −45,577 $66.47 $3,029,503 1,917,375 D
2019-12-13 Sale : show line 7 in the form −25,412 $67.30 $1,710,228 1,891,963 D
2019-12-13 Sale : show line 8 in the form −3,393 $68.18 $231,335 1,888,570 D
Open-market sales · 183,333 sh · avg $67.15 · $12,310,119
Loading xslF345X03/doc4.xml…